Skip to content

Clinical trials

Phase 2 Immune System Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 2 Country / region: Spain Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20131
20151
20161
20171
20192
20201
20213
20222
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8
Active, not recruiting5
Completed5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cogent Biosciences, Inc.2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Alumis Inc1
Beeline Medicines Corporation1
Diamyd Medical AB1
Eli Lilly and Company1
European Association of Urology Research Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases19
Autoimmune Diseases11
Connective Tissue Diseases4
Joint Diseases3
Lupus Erythematosus, Systemic3
Rheumatic Diseases3
Skin Diseases3
Arthritis2
Arthritis, Rheumatoid2
Dermatitis2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.